Inovio Plummets After Planned Phase 2/3 Coronavirus Vaccine Study Put On Partial Clinical HoldBenzinga • 09/28/20
Inovio Pharmaceuticals, Inc. (INO) President & CEO Joseph Kim Presents at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit TranscriptSeeking Alpha • 09/23/20
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Cantor 2020 Global Virtual Healthcare Conference Call TranscriptSeeking Alpha • 09/17/20
At This Point, There’s No Reason to Buy (or Dump) Inovio Pharmaceuticals StockInvestorPlace • 09/17/20